AKOYA BIOSCIENCES INC

Akoya to Participate at Two Upcoming Investor Conferences

12 Jun 2023 15:05:08 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Pricing of Public Offering of Common Stock

07 Jun 2023 23:55:49 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Public Offering of Common Stock

07 Jun 2023 15:08:11 By Nasdaq GlobeNewswire

Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance

08 May 2023 15:05:08 By Nasdaq GlobeNewswire

Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument

27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023

06 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Leadership Transition

20 Mar 2023 15:00:00 By Nasdaq GlobeNewswire

Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance

06 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel

28 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences

06 Feb 2023 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting

01 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022

08 Jan 2023 15:00:00 By Nasdaq GlobeNewswire

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day

15 Dec 2022 15:00:00 By Nasdaq GlobeNewswire

Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance

07 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy

07 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Akoya to Participate at Three Upcoming Investor Conferences

03 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

11 Oct 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Participate at Four Upcoming Investor Conferences

31 Aug 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance

08 Aug 2022 15:05:01 By Nasdaq GlobeNewswire